Physician profile
Shrey Modi
NPI 1336671593
$2,700.64
in general payments reported to CMS, 2019-2025
10 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $252 · 2021: $17.52 · 2022: $397 · 2023: $1,616 · 2024: $129 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,267 · Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,267.16 |
| Food and Beverage | $604.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,380.16 | 2023-2024 | Da Vinci Surgical System |
| Lantheus Medical Imaging, INC. | $289.74 | 2019-2020 | |
| Medtronic, INC. | $173.34 | 2023-2025 | Interstim, Signia |
| Boston Scientific Corporation | $147.66 | 2022 | |
| Davol INC. | $128.43 | 2021-2024 | Phasix Mesh |
| E.R. Squibb & Sons, L.L.C. | $124.89 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $124.86 | 2022 | |
| Akcea Therapeutics, INC. | $124.73 | 2020 | |
| Becton, Dickinson and Company | $105.84 | 2023 | Phasix Mesh |
| Olympus Corporation of The Americas | $100.99 | 2023 | Evis Exera Lll Colonovideoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shrey Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.